Serotonergic neuronal atrophy with synaptic inactivation, not axonal degeneration, are the main hallmarks of multiple sclerosis

International Journal of Neuroscience

Volumn 95, Issue 1-2, 1998, Pages 133-140

  Sandyk, Reuven ^a  

^a TOURO COLLEGE   (United States)

Author keywords

Electromagnetic fields; Multiple sclerosis; Neuronal atrophy; Neuronal degeneration; Serotonin; Synaptic inactivation

Indexed keywords

EID: 0032125391     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.3109/00207459809000656     Document Type: Article

References (58)

1. Aldegunde, M., Miguez, I. & Veira, J. (1985) Effects of pinealectomy on regional brain serotonin metabolism. International Journal of Neuroscience, 26, 9-13.
2. Antolin, I , Rodriguez, C., Sainz, R. M., Mayo, J., Uria, H., Kotler, M. L., Rodriguez-Colunga, M. J., Tolivia, D. & Menedez-Pelaez, A. (1996) Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB Journal, 10, 882-890.
3. Anton-Tay, F., Chou, C., Anton, S. & Wurtman, R. J (1968) Brain serotonin concentration: elevation following intraperitoneal administration of melatonin. Science, 162, 277-278.
4. Azanza, M. J. & Del Moral, A. (1994) Cell membrane biochemistry and neurobiological approach to biomagnetism. Progress in Neurobiology, 44, 517-601.
5. Barlow-Walden, L. R., Reiter, R. J., Abe, M., Pablos, M., Menendez-Pelaez, A., Chen, L. D & Poeggeler, B. (1995) Melatonin stimulates brain glutathione peroxidase activity. Neurochemistry International, 26, 497-502.
6. Baumgarten, H. G. & Lachenmayer, L. (1985) Anatomical features and physiological properties of central serotonin neurons. Pharmacopsychiatry, 18, 180-187.
7. Baumgarten, H. G., Lachenmayer, L. & Bjorklund, A. (1977) Chemical lesioning of indoleamine pathways. In Myers, R. D (Ed.), Methods in Psychobiology, 3, 47-98. New York: Academic press.
8. Carlsson, A., Magnusson, T. & Rosengren, E. (1963) 5-hydroxytryptamine of the spinal cord normally and after transection. Experientia, 19, 359.
9. Charcot, M. (1868) Histologie de la sclerose en plaques. Gazette Hospitale, 141, 554-555.
10. Davidson, D., Pullar, I. A., Mawdsley, C., Kinloch, N. & Yates, C. M. (1977) Monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 40, 741-745.
11. Devoino, L., Idova, G., Alperina, E. & Cheido, M. (1987) Distribution of immunocompetent cells underlying psychoneuroimmunomodulation. Brain neuromediator control mechanisms. Annals of the New York Academy of Sciences, 496, 292-300.
12. Flax, J. W., Gray, J. & Herbert, J. (1991) Effect of fluoxetine on patients with multiple sclerosis. American Journal of Psychiatry, 148, 1603
13. Gareri, P., Mattace, R., Nava, F & De Sarro, G. (1995) Role of calcium in brain aging. General Pharmacology, 26, 1651-1657.
14. Georgi, W. (1961) Multiple sclerose: pathologische-anatomische befunde multiple sclerose bei klinisch nicht diagnostizierten krankheiten. Schweizerischer Medizinische Wochenschrift, 91, 605-607.
15. Ghatak, N. R., Hirano, A., Lijtmaer, H. & Zimmerman, H. M. (1974) Asymptomatic demyelinated plaque in the spinal cord. Archives of Neurology, 30, 484-486.
16. Haymaker, W. (1969) Bing's local diagnosis in neurological diseases (pp. 357-359). Saint Louis: The C. V. Mosby Company.
17. Hopper, C. L., Matthews, C. G. & Cleeland, C. S. (1972) Symptom instability and thermo-regulation in multiple sclerosis. Neurology, 22, 142-148.
18. Hyyppa, M T., Jolma, T., Riekkinen, P. & Rinne, U. K. (1975) Effects of L-tryptophan on central indoleamine metabolism and short-lasting neurologic disturbances in multiple sclerosis. Journal of Neural Transmission, 37, 297-304.
19. Jacobs, B. L. & Fornal, C. A. (1993) 5-HT and motor control: a hypothesis. Trends in Neurosciences, 16, 346-352
20. Jankovic, B. D., Isakovic, K. & Petrovic, S. (1970) Effect of pinealectomy on immune reactions in the rat. Immunology, 18, 1-5.
21. Johansson, B. & Ross, B. E. (1977) 5-hydroxyindoleacetic acid and homovanillic acid in CSF of patients with neurological disease. European Neurology, 11, 37-45.
22. Kisser, W. & Harrer, G. (1974) Amino acid determinations in serum of patients with multiple sclerosis. Wiener Klinische Wochenschrift, 86, 80-82.
23. Lynch, S. G., Rose, J. W., Smoker, W. & Petajan, J. H. (1990) MRL in familial multiple sclerosis. Neurology, 40, 900-903.
24. Manev, H., Uz, T., Kharlamov, A. & Joo, J. Y. (1996) Increased brain damage after stroke or excitotoxic seizures in melatonin-deficient rats. FASEB Journal, 10, 1546-1551.
25. Matthews, W. B (1978) Multiple sclerosis. In Matthews, W. B. & Glaser, G. H. (Eds.), Recent advances in clinical neurology, p. 4, Edinburgh: Churchill Livingstone.
26. Matthews, W. B. & Glaser, G. H. (1978) Recent advances in clinical neurology, p. 4, Edinburgh: Chruchill Livingstone, 1978.
27. Miguez, J. M., Martin, F. & Aldegunde, M. (1991) Long-term pinealectomy alters hypothalamic serotonin metabolism in the rat. Journal of Pineal Research, 11, 75-79.
28. Miguez, J. M., Martin, F. J. & Aldegunde, M. (1994) Effects of single doses and daily melatonin treatments on serotonin metabolism in rat brain regions. Journal of Pineal Research, 17, 170-176.
29. Millard, S. A., Costa, E & Gal, E. M. (1972) On the control of brain serotonin turnover rate by end product inhibition. Brain Research, 40, 545-552.
30. O'Brien, D. J., Hughes, F. W. & Newberne, J. (1962) Influence of lysergic acid diethylamide on experimental allergic encephalomyelitis. Proceedings of the Society of Experimental Biology, 111, 490-493.
31. Persson, H. E. & Sachs, C. (1978) Provoked visual impairment in multiple sclerosis studied by visual evoked responses. Electroencephalography and Clinical Neurophysiology, 44, 666-668.
32. Phadke, J. G. & Best, P. V. (1983) A typical and clinically silent multiple sclerosis: a report of 12 cases discovered unexpectedly at necropsy. Journal of Neurology, Neurosurgery and Psychiatry, 46, 414-420.
33. Pieri, C., Marra, M., Moroni, F. & Marcheselli, F. (1994) Melatonin: a peroxyl radical scavenger more effective than vitamin E Pergamon, 55, 271-276.
34. Reiter, R. J. (1995) Oxidative processes and antioxidative defense mechanism in the aging brain. FASEB Journal, 9, 526-533.
35. Russel, D. S. (1964) Trauma and multiple sclerosis. Lancet, 1, 978.
36. Sandyk, R. (1992) Successful treatment of multiple sclerosis with magnetic fields. International Journal of Neuroscience, 66, 237-250.
37. Sandyk, R. (1993) Demyelination as an epiphenomenon in multiple sclerosis. International Journal of Neuroscience, 72, 141-148.
38. Sandyk, R. (1994a) Reversal of visuospatial hemi-inattention in patients with chronic progressive multiple sclerosis by treatment with weak electromagnetic fields. International Journal of Neuroscience, 79, 169-184.
39. Sandyk, R. (1994b) Rapid normalization of visual evoked potential by picotesla range magnetic fields in chronic progressive multiple sclerosis. International Journal of Neuroscience, 77, 243-259.
40. Sandyk, R. (1995a) Chronic relapsing multiple sclerosis; a case of rapid recovery by application of weak electromagnetic fields. International Journal of Neuroscience, 82, 223-242.
41. Sandyk, R. (1995b) Long term beneficial effects of weak electromagnetic fields in multiple sclerosis. International Journal of Neuroscience, 83, 45-57.
42. Sandyk, R. (1996) Treatment with electromagnetic fields alters the clinical course of chronic progressive multiple sclerosis: a case report. International Journal of Neuroscience, 88, 75-82.
43. Sandyk, R. (1997a) Treatment with electromagnetic fields reverses the long term clinical course of a patient with chronic progressive multiple sclerosis. International Journal of Neuroscience, 90, 177-186.
44. Sandyk, R. (1997b) Therapeutic effects of AC pulsed electromagnetic fields in multiple sclerosis. Journal of Alternative and Complementary Medicine, 3, 365-386.
45. Sandyk, R (1997c) Immediate recovery of cognitive functions and resolution of fatigue by treatment with weak electromagnetic fields in a patient with multiple sclerosis. International Journal of Neuroscience, 90, 59-74.
46. Sandyk, R. (1997d) Lack of a correlation between demyelinating plaques on MRI scan and clinical recovery in multiple sclerosis by treatment with electromagnetic fields. Inter. J. Neuroscience, 89, 29-38.
47. Sandyk, R (1997e) Role of the pineal gland in multiple sclerosis: a hypothesis. Journal of Alternative and Complementary Medicine, 3, 267-290
48. Sandyk, R. (in Press) Treatment with AC pulsed electromagnetic fields normalizes the latency of the visual evoked response in a multiple sclerosis patient with optic atrophy. International Journal of Neuro science.
49. Sandyk, R. & Derpapas, K. (1993) Magnetic fields normalize visual evoked potentials and brainstem auditory evoked potentials in multiple sclerosis. International Journal of Neuroscience, 68, 241-253.
50. Sandyk, R. & Iacono, R. P (1993) Resolution of longstanding symptoms of multiple sclerosis by application of picotesla range magnetic fields. International Journal of Neuroscience, 70, 255-269.
51. Sandyk, R. & Iacono, R. P. (1994) Improvement by picotesla magnetic fields of perceptual-motor performance in a patient with chronic progressive multiple sclerosis. International Journal of Neuroscience, 78, 53-66
52. Sonnien, V., Riekkinen, P. & Rinne, U. K. (1973) Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology, 23, 760-763.
53. Symington, G. R., MaCKay, I. R. & Currie, T. T. (1977) Improvement in multiple sclerosis during prolonged induced hypothermia. Neurology, 27, 302-303.
54. Telegdy, G. & Vermes, I. (1975) Effect of adrenocortical hormones on activity of the serotoninergic system in limbic structures in rats. Neuroendocrinology, 18, 16-26.
55. Trapp, B D., Peterson, J , Ransohoff, R. M., Rudick, R., Mork, S. & Bo, L. (1998) Axonal transection in the lesions of multiple sclerosis. New England Journal of Medicine, 338, 278-285.
56. Vost, A., Wolochow, D. A. & Howell, D. A. (1964) Incidence of infarcts of the brain in heart disease. Journal of Pathology and Bacteriology, 88, 463-470.
57. Vuia, A. (1977) The beginning form of multiple sclerosis. anatomo-clinical aspects. Acta Neurologica Scandinavica, 55, 289-293.
58. Watson, C. W. (1959) Effect of lowering of body temperature on the symptoms and signs of multiple sclerosis. New England Journal of Medicine, 261, 1253-1259.